Lily E. Adams

1.6k total citations
17 papers, 788 citations indexed

About

Lily E. Adams is a scholar working on Molecular Biology, Infectious Diseases and Ecology. According to data from OpenAlex, Lily E. Adams has authored 17 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Infectious Diseases and 4 papers in Ecology. Recurrent topics in Lily E. Adams's work include SARS-CoV-2 and COVID-19 Research (6 papers), Bacteriophages and microbial interactions (4 papers) and Viral gastroenteritis research and epidemiology (3 papers). Lily E. Adams is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (6 papers), Bacteriophages and microbial interactions (4 papers) and Viral gastroenteritis research and epidemiology (3 papers). Lily E. Adams collaborates with scholars based in United States, Australia and New Zealand. Lily E. Adams's co-authors include André O. Hudson, Anutthaman Parthasarathy, Penelope J. Cross, Renwick C. J. Dobson, Michael A. Savka, Ralph S. Baric, Yixuan J. Hou, Boyd L. Yount, Timothy P. Sheahan and Kenneth H. Dinnon and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Virology.

In The Last Decade

Lily E. Adams

16 papers receiving 782 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lily E. Adams United States 11 417 227 113 90 85 17 788
Feng Huang China 18 269 0.6× 407 1.8× 51 0.5× 249 2.8× 29 0.3× 47 958
Saif ur Rehman China 14 159 0.4× 251 1.1× 30 0.3× 55 0.6× 39 0.5× 61 796
Jan Šilhán Czechia 15 319 0.8× 869 3.8× 22 0.2× 107 1.2× 64 0.8× 29 1.2k
Koichi Murakami Japan 20 257 0.6× 148 0.7× 17 0.2× 123 1.4× 22 0.3× 71 1.0k
Sabrina Petricca Italy 15 168 0.4× 173 0.8× 21 0.2× 23 0.3× 41 0.5× 23 605
James W. Boles United States 10 213 0.5× 335 1.5× 45 0.4× 110 1.2× 28 0.3× 14 685
Suman Pakala United States 16 193 0.5× 406 1.8× 27 0.2× 57 0.6× 170 2.0× 33 836
Alicia Irurzun Spain 17 151 0.4× 360 1.6× 21 0.2× 116 1.3× 196 2.3× 23 875

Countries citing papers authored by Lily E. Adams

Since Specialization
Citations

This map shows the geographic impact of Lily E. Adams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lily E. Adams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lily E. Adams more than expected).

Fields of papers citing papers by Lily E. Adams

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lily E. Adams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lily E. Adams. The network helps show where Lily E. Adams may publish in the future.

Co-authorship network of co-authors of Lily E. Adams

This figure shows the co-authorship network connecting the top 25 collaborators of Lily E. Adams. A scholar is included among the top collaborators of Lily E. Adams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lily E. Adams. Lily E. Adams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Zhou, Shuntai, Nathan Long, Collin S Hill, et al.. (2024). Impact of Low-Frequency Human Immunodeficiency Virus Type 1 Drug Resistance Mutations on Antiretroviral Therapy Outcomes. The Journal of Infectious Diseases. 230(1). 86–94. 1 indexed citations
2.
Adams, Lily E., Jaclyn S. Higgins, Kara Anasti, et al.. (2024). Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions. PLoS Pathogens. 20(6). e1011569–e1011569. 10 indexed citations
3.
Henning, Lisa N., Michael S. Anderson, Tammy Smith, et al.. (2023). Efficacy of different AV7909 dose regimens in a nonclinical model of pulmonary anthrax. Human Vaccines & Immunotherapeutics. 19(3). 2290345–2290345. 4 indexed citations
4.
Narowski, Tara M., Lily E. Adams, Nadja A. Vielot, et al.. (2022). SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people. Cell Reports. 38(5). 110336–110336. 32 indexed citations
5.
Tse, Longping V., Rita M. Meganck, Lily E. Adams, et al.. (2022). Generation of Mature DENVs via Genetic Modification and Directed Evolution. mBio. 13(3). e0038622–e0038622. 12 indexed citations
6.
Tse, Longping V., Rita M. Meganck, Boyd L. Yount, et al.. (2022). Genomewide CRISPR knockout screen identified PLAC8 as an essential factor for SADS-CoVs infection. Proceedings of the National Academy of Sciences. 119(18). e2118126119–e2118126119. 24 indexed citations
7.
Dinnon, Kenneth H., Sarah R. Leist, Alexandra Schäfer, et al.. (2021). Publisher Correction: A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures. Nature. 590(7844). E22–E22. 7 indexed citations
8.
Adams, Lily E., Kenneth H. Dinnon, Yixuan J. Hou, et al.. (2021). Critical ACE2 Determinants of SARS-CoV-2 and Group 2B Coronavirus Infection and Replication. mBio. 12(2). 4 indexed citations
10.
Dinnon, Kenneth H., Sarah R. Leist, Alexandra Schäfer, et al.. (2020). A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures. Nature. 586(7830). 560–566. 381 indexed citations
11.
Adams, Lily E., André O. Hudson, Lindsay W. Black, et al.. (2020). A Cut above the Rest: Characterization of the Assembly of a Large Viral Icosahedral Capsid. Viruses. 12(7). 725–725. 10 indexed citations
12.
Parthasarathy, Anutthaman, et al.. (2019). The Arabidopsis thaliana gene annotated by the locus tag At3g08860 encodes alanine aminotransferase. Plant Direct. 3(9). e00171–e00171. 22 indexed citations
13.
Babbitt, Gregory A., et al.. (2019). DROIDS 3.0—Detecting Genetic and Drug Class Variant Impact on Conserved Protein Binding Dynamics. Biophysical Journal. 118(3). 541–551. 10 indexed citations
14.
Adams, Lily E., Gregory A. Babbitt, & André O. Hudson. (2019). Using Molecular Dynamics Simulations to Evaluate Ligand Binding of L, L‐diaminopimelate Aminotransferase, an Enzyme Involved in Protein and Peptidoglycan Biosynthesis. The FASEB Journal. 33(S1). 1 indexed citations
15.
Babbitt, Gregory A., et al.. (2018). DROIDS 1.20: A GUI-Based Pipeline for GPU-Accelerated Comparative Protein Dynamics. Biophysical Journal. 114(5). 1009–1017. 11 indexed citations
16.
Parthasarathy, Anutthaman, Penelope J. Cross, Renwick C. J. Dobson, et al.. (2018). A Three-Ring Circus: Metabolism of the Three Proteogenic Aromatic Amino Acids and Their Role in the Health of Plants and Animals. Frontiers in Molecular Biosciences. 5. 29–29. 242 indexed citations
17.
Weintraub, Susan T., Lily E. Adams, Weimin Wu, et al.. (2018). Global Proteomic Profiling of Salmonella Infection by a Giant Phage. Journal of Virology. 93(5). 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026